Active	Status	Sponsor type	Region	Phase	Filter
13 Active 11 Inactive 24 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sharma, Sunil
NCT04471415 / 2020-002770-27: Study to Investigate DRP-104 in Adults With Advanced Solid Tumors	Terminated	2a	61	Europe, US, RoW	DRP-104, atezolizumab	Dracen Pharmaceuticals, Inc., Dracen Pharmaceuticals, Inc.	Advanced Solid Tumor, Non Small Cell Lung Cancer Metastatic	03/23	03/23
C-800-25, NCT05608044: A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer	Active, not recruiting	2	234	Europe, US, RoW	Botensilimab, AGEN1181, Balstilimab, AGEN2034, Standard of Care	Agenus Inc.	Metastatic Colorectal Cancer	02/25	07/25
NCT01726101: Dose-Escalation and Safety Trial of YN968D1	Recruiting	1/2	42	US, RoW	YN968D1, Apatinib	Bukwang Pharmaceutical, Co., Ltd., LSK BioPartners Inc.	Cancer Patients With Solid Tumors	06/15	08/15
NCT04381650 / 2020-004325-23: A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors	Active, not recruiting	1/2	49	Europe, Japan, US, RoW	TAK-981, Pembrolizumab	Takeda, Takeda Development Center Americas, Inc.	Advanced or Metastatic Solid Tumors	11/25	11/25
NCT03715933: Phase 1 Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas	Recruiting	1	321	Europe, US	INBRX-109, Carboplatin, Cisplatin, Pemetrexed, 5-fluorouracil, Irinotecan, Temozolomide	Inhibrx Biosciences, Inc	Colorectal Adenocarcinoma, Ewing Sarcoma	06/26	12/26
FX-909-CLINPRO-1, NCT05929235: A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma	Recruiting	1	75	US	FX-909	Flare Therapeutics Inc.	Advanced Solid Tumors Cancer, Advanced Urothelial Carcinoma, Oral Drug Administration, Open Label	09/26	01/27
NCT06055920: The PEERLESS II Study	Recruiting	N/A	1200	Europe, Canada, US	FlowTriever System, Anticoagulation Agents	Inari Medical	Pulmonary Embolism	07/26	07/26
rēST Study, NCT03884660: Remedē System Therapy Study	Recruiting	N/A	500	Europe, US	remede System	Respicardia, Inc.	Central Sleep Apnea	06/27	06/32